General Anesthesia Drug Market - Trends Forecast Till 2028

General Anesthesia Drug Market, by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centres) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: February, 2021

Base Year Estimate: 2020

Report ID: D-PH-GADM-96

Format:  

Number of Pages: 266

Domain: Pharmaceutical

General Anesthesia Drug Market – Trends Forecast Till 2028

The global general anesthesia drug market is anticipated to reach USD 6.8 billion in 2021 growing at a CAGR of 5.2% during the forecasting period, 2021-2028. 

Anesthesia drugs also popularly known as anesthetics are used to induce a general loss of sensation in the body. It does so by suppressing the sensory stimulation through acting on the brain and PNS (peripheral nervous system). These drugs are classified into 3 major types 1. General anesthesia 2. Local anesthesia 3. Regional anesthesia. General anesthesia leads to a loss of consciousness whereas in the case of local anesthesia there is a loss of sensation in a particular area which is achieved by blocking the conduction in nerves. Anesthesia can be given intravenously or can also be snorted. Some common drugs used to produce anesthesia are Barbiturates, Benzodiazepines, Etomidate, etc.

With a recent surge in cancer patients and emergency, surgeries are some of the factors that have supported long-term expansion for the global general anesthesia drug industry. 

General Anesthesia Drug Market – Trends Forecast Till 2028

Global general anesthesia drug market is segmented into the route of administration, end-user, and geography.

Route of Administration segment is segmented into Intravenous and Inhalational.

End-User segment is segmented into Hospitals, Ambulatory Surgery Centres.

Geographically, the global general anesthesia drug market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America and insights are provided for each region and major countries within the regions

Key players in the global general anesthesia drug market are Baxter International Inc. (US), Hikma Pharmaceuticals plc (UK), Pfizer Inc. (US), Piramal Enterprises Limited (India), AbbVie (US), Fresenius SE & Co. KGaA (Germany), Par Pharmaceutical (US), Teva Pharmaceuticals (Israel), Viatris/Mylan (US), Novartis AG (US), Abbott Laboratories (US), AstraZeneca plc (US), F.Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (UK), Gilead Sciences, Inc. (US), Bayer AG (Germany), Merck & Co., Inc. (Germany), Sanofi (France), Heritage Pharmaceuticals Inc. (US), Akorn (US), and Apotex (Canada) among others. 

Available Customizations

In addition to the market data for the Global general anesthesia drug market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conferences like Jefferies conference)—to identify and collect information useful for this study of the Global general anesthesia drug market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial studies the global general anesthesia drug market. Through secondary research, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological development. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the Global general anesthesia drug market.

Primary Respondent breakdown is given below:

Primary Respondents

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the Global general anesthesia drug market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the global general anesthesia drug market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 6.8 billion

Growth Rate

CAGR of 5.2% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year 

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Route of administration, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Baxter International Inc. (US), Hikma Pharmaceuticals plc (UK), Pfizer Inc. (US), Piramal Enterprises Limited (India), AbbVie (US), Fresenius SE & Co. KGaA (Germany), Par Pharmaceutical (US), Teva Pharmaceuticals (Israel), Viatris/Mylan (US), Novartis AG (US), Abbott Laboratories (US), AstraZeneca plc (US), F.Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (UK), Gilead Sciences, Inc. (US), Bayer AG (Germany), Merck & Co., Inc. (Germany), Sanofi (France), Heritage Pharmaceuticals Inc. (US), Akorn (US), and Apotex (Canada).

Available Customization 

In addition to the market data for the global general anesthesia drug market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.